Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-21

Clinical Trial Update: Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients

View source ↗

Summary

A completed clinical trial evaluating the efficacy and tolerability of Testogel and Nebido in combination with exercise and diet for hypogonadal men.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebido (testosterone undecanoate)
  • Testogel (testosterone)

Snippet

Sponsor: Bayer | Conditions: Hypogonadism | Status: COMPLETED